| Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease A Wilson, A Almousa, WA Teft, RB Kim Scientific Reports 10 (1), 1866, 2020 | 41 | 2020 |
| Inhibition of ABC transport proteins by oil sands process affected water HA Alharbi, DMV Saunders, A Al-Mousa, J Alcorn, AS Pereira, JW Martin, ... Aquatic Toxicology 170, 81-88, 2016 | 37 | 2016 |
| Membrane permeability of trace amines: Evidence for a regulated, activity‐dependent, nonexocytotic, synaptic release MD Berry, MR Shitut, A Almousa, J Alcorn, B Tomberli Synapse 67 (10), 656-667, 2013 | 37 | 2013 |
| Elevation of serum pyruvate kinase M2 (PKM2) in IBD and its relationship to IBD indices AA Almousa, M Morris, S Fowler, J Jones, J Alcorn Clinical biochemistry 53, 19-24, 2018 | 31 | 2018 |
| Linoorbitides and enterolactone mitigate inflammation-induced oxidative stress and loss of intestinal epithelial barrier integrity AA Almousa, F Meurens, ES Krol, J Alcorn International Immunopharmacology 64, 42-51, 2018 | 30 | 2018 |
| Influence of flaxseed lignan supplementation to older adults on biochemical and functional outcome measures of inflammation Y Di, J Jones, K Mansell, S Whiting, S Fowler, L Thorpe, J Billinsky, ... Journal of the American College of Nutrition 36 (8), 646-653, 2017 | 29 | 2017 |
| Pharmacogenomics in the era of next generation sequencing–from byte to bedside LE Russell, Y Zhou, AA Almousa, JK Sodhi, CK Nwabufo, VM Lauschke Drug Metabolism Reviews 53 (2), 253-278, 2021 | 26 | 2021 |
| HPLC-UV method development for fentanyl determination in rat plasma and its application to elucidate pharmacokinetic behavior after ip administration to rats AA Almousa, R Ikeda, M Wada, N Kuroda, RK Hanajiri, K Nakashima Journal of Chromatography B 879 (27), 2941-2944, 2011 | 23 | 2011 |
| Protocol for a 24-week randomized controlled study of once-daily oral dose of flax lignan to healthy older adults J Alcorn, S Whiting, N Viveky, Y Di, K Mansell, S Fowler, L Thorpe, ... JMIR research protocols 6 (2), e6817, 2017 | 14 | 2017 |
| Toxicokinetics and toxicodynamics of chlorpyrifos is altered in embryos of Japanese medaka exposed to oil sands process‐affected water: evidence for inhibition of P‐glycoprotein HA Alharbi, J Alcorn, A Al‐Mousa, JP Giesy, SB Wiseman Journal of applied toxicology 37 (5), 591-601, 2017 | 13 | 2017 |
| An automated approach to identify scientific publications reporting pharmacokinetic parameters FG Hernandez, SJ Carter, J Iso-Sipilä, P Goldsmith, AA Almousa, ... Wellcome Open Research 6, 2021 | 11 | 2021 |
| Genetic variation in the farnesoid X-receptor predicts Crohn’s disease severity in female patients A Wilson, Q Wang, AA Almousa, LE Jansen, Y Choi, UI Schwarz, RB Kim Scientific Reports 10 (1), 11725, 2020 | 11 | 2020 |
| Lignan enterolactone modulates cellular lipid and cholesterol homeostasis linking diverse molecular mechanisms F De Silva, X Yang, A Almousa, A Hawsawai, J Alcorn Drug Metabolism and Pharmacokinetics 34 (1), S33, 2019 | 1 | 2019 |
| Local effects of Linoorbitides and Enterolactone on intestinal epithelial functions AA Almousa University of Saskatchewan Saskatoon, 2017 | 1 | 2017 |
| Population Pharmacokinetic Model Development of Autologous CD30.CAR-T Cells in Relapsed or Refractory Classical Hodgkin Lymphoma Patients A. Almousa, R.Balyan, A.Myo, L. Go Clinical Pharmacology in Drug Development, 2023 | | 2023 |
| Prolonged absorption and susceptibility to enterohepatic circulation after oral administration of ergot alkaloids in ewes A Almousa, R Yonpiam, B Blakley, AN Al-Dissi Canadian Journal of Veterinary Research 86 (2), 108-112, 2022 | | 2022 |
| Acetazolamide Induced Hypersensitivity Reaction In A Pediatric Low-Grade Glioma Patient: A Case Report O Tremblay, AA Almousa Professional Practice Conference, Canadian Society Of Hospital Pharmacy, 2021 | | 2021 |
| A214 GENETIC VARIATION IN THE FARNESOID X RECEPTOR PREDICTS CROHN’S DISEASE SEVERITY IN FEMALE PATIENTS A Wilson, Q Wang, A Almousa, L Jansen, Y Choi, UI Schwarz, R Kim Journal of the Canadian Association of Gastroenterology 3 (Supplement_1), 87-88, 2020 | | 2020 |
| Xenobiotic nuclear receptors: linking bile acid signalling to alterations in CYP3A4 metabolism in Crohn's disease A Wilson, A Almousa, R Rose, W Teft, R Kim JOURNAL OF CROHNS & COLITIS 13, S126-S126, 2019 | | 2019 |
| MRP4 (ABCC4) is a determinant of observed capecitabine and its metabolite concentrations during cancer therapy AA Almousa Drug Metabolism and Pharmacokinetics 34 (1), S64, 2019 | | 2019 |
Jane AlcornProfessor of Pharmacy, University of SaskatchewanVerified email at usask.ca
